Advertisement

Komplikationen und Nebenwirkungen von Bluttransfusionen

  • D. Roelcke

Zusammenfassung

Transfusionsreaktionen können nach verschiedenen Gesichtspunkten gegliedert werden. Jede Gliederung hat ihre Vor- und Nachteile. Eine Einteilung nach Sofort- und verzögerten Reaktionen hat auf den ersten Blick den Vorteil, praxisnah zu sein, jedoch den Nachteil, daß heterogene Reaktionen zusammengefaßt und ätiologisch eng verwandte Reaktionen getrennt werden müßten. Eine Gliederung nach der klinischen Symptomatik wäre besonders praxisgerecht, doch auch sie hätte den Nachteil, nicht gleichzeitig auch ätiologisch plausibel durchgehalten werden zu können. Hier wird der Einteilung nach ätiologischen Gesichtspunkten der Vorzug gegeben.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aster RH (1984) Clinical significance of platelet-specific antigens and antibodies. Advances in Im-munobiology: Blood cell antigens and bone marrow transplantation (ed. by J. McCullough and S. Sandler), p. 103. Alan R. Liss, New York.Google Scholar
  2. 2.
    Aster RH (1985) Personal communication to Becker et al. cited in Becker T, Panzer S, Maas D, Kiefel V, Sprenger R, Kirschbaum M, Muel-ler-Eckhardt C. Br J Haematol 61:149–155.Google Scholar
  3. 3.
    Avoy DR (1981) Delayed serum sickness-like transfusion reactions in a multiply transfused patient. Vox Sang 41:239–244.PubMedCrossRefGoogle Scholar
  4. 4.
    Barton JC (1981) Nonhemolytic, noninfectious transfusion reactions. Semin Hematol 18:95–121.PubMedGoogle Scholar
  5. 5.
    Becker T, Panzer S, Maas D, Kiefel V, Sprenger R, Kirschbaum M, Mueller-Eckhardt C (1985) High-dose intravenous immunoglobulin for posttransfusion purpura. Br J Haematol 61:149–155.PubMedCrossRefGoogle Scholar
  6. 6.
    Berney SI, Metcalfe P, Wathen NC, Waters AH (1985) Post-transfusion purpura (PTP) responding to high-dose intravenous IgG: further observations on pathogenesis. Br J Haematol 61:627–632.PubMedCrossRefGoogle Scholar
  7. 7.
    Boizard B, Wautier J-L (1984) Leka, a new platelet antigen absent in Glanzmann’s thrombasthenia. Vox Sang 46:47–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Borne AEG Kr von dem, Verheugt FWA, Oosterhof F, Riesz E von, Brutel de la riviere A, Engelfriet CP (1978) A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 39:195–207.CrossRefGoogle Scholar
  9. 9.
    Borne AEG Kr von dem, Plasvan Dalen CM van der (1985) Further observation on post-transfusion purpura (PTP). (Letter). Br J Haematol 61:374–375.CrossRefGoogle Scholar
  10. 10.
    Borne AEG Kr von dem, Plasvan Dalen CM van der (1986) Baka and Leka are identical antigens. Br J Haematol 62:404–405.CrossRefGoogle Scholar
  11. 11.
    Braude AI (1958) Transfusion reactions from contaminated blood: their recognition and treatment. N Engl J Med 258:1289–1293.PubMedCrossRefGoogle Scholar
  12. 12.
    Brittingham TE, Chaplin H (1957) Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA 165:819–825.CrossRefGoogle Scholar
  13. 13.
    Brittingham TE, Chaplin H (1961) The antigenicity of normal and leukemic human leukocytes. Blood 17:139–165.Google Scholar
  14. 14.
    Brubaker DB (1983) Human posttransfusion graft-versus-host disease. Vox Sang 45:401–420.PubMedCrossRefGoogle Scholar
  15. 15.
    Buskard NA, Kaur J, Goldman JM, Spiers ASD, Galton DAG (1979) Engraftment with chronic granulocytic leukemia cells in acute myeloid leukemia. Transfusion 19:317–320.PubMedCrossRefGoogle Scholar
  16. 16.
    Cartron JP, Ropars C, Salmon C, Salmon D (1973) Teneurs en IgE des serums des malades polytransfuses. Rev Fr Transfus 16:385–392.PubMedCrossRefGoogle Scholar
  17. 17.
    Cartron JP, Ropars C, Cartron J, Salmon C (1974) Elevated IgE levels in the serum of mul-titransfused patients. Possible role in transfusion reactions. Immunology 27:923–928.Google Scholar
  18. 18.
    Cohen D, Weinstein H, Mihm M, Yankee R (1979) Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors. Blood 53:1053–1057.PubMedGoogle Scholar
  19. 19.
    Comparini SO, Vyas GN, Frick OL (1978) Personal communication to Mollison PL cited in Mollison PL: Blood Transfusion in Clinical Medicine, 7th Ed, Blackwell Sci Publ, Oxford, p 744, 1983.Google Scholar
  20. 20.
    Contreras TJ, Sheibley RH, Valeri CR (1974) Accumulation of di-2-ethylhexyl phthalate (DEHP) in whole blood, platelet concentrates, and platelet-poor plasma. Transfusion 14:34–46.PubMedCrossRefGoogle Scholar
  21. 21.
    Croucher BEE, Crookston MC, Crookston JH (1967) Delayed haemolytic transfusion reactions simulating auto-immune haemolytic anemia. Vox Sang 12:32–42.CrossRefGoogle Scholar
  22. 22.
    Décary F, Vermeulen A, Engelfriet CP (1975) A look at HLA antisera in the HFT. Histocompatibility Testing, Munksgaard, Copenhagen, p 380.Google Scholar
  23. 23.
    Décary F, Ferner P, Giavedoni L, Hartmann A, Howie R, Kalovsky E, Laschinger C, Malette M, Martyres A, Mervart H, Naylor DH, Rose JEM St, Shepherd FA, Tibensky D (1984) An investigation of nonhemolytic transfusion reactions. Vox Sang 46:277–285.PubMedCrossRefGoogle Scholar
  24. 24.
    Deutsches Ärzteblatt 80:35–38 (1983) Empfehlungen für die Behandlung von Transfusionszwischenfällen.Google Scholar
  25. 25.
    Dinsmore RE, Straus DJ, Pollack MS, Woodruff JM, Garrett TJ, Young CW, Clarkson BD, Du-pont B (1980) Fatal graft-versus-host disease following blood transfusion in Hodgkin’s disease documented by HLA typing. Blood 55:831–834.PubMedGoogle Scholar
  26. 26.
    Elin RJ, Lundberg WB, Schmidt PJ (1975) Evaluation of bacterial contamination in blood processing. Transfusion 15:260–265.PubMedCrossRefGoogle Scholar
  27. 27.
    Engelfriet CP, Borne AEG Kr von dem, Beckers D, Loghem JJ van (1974) Autoimmune haemolytic anaemia: serological and immunochemical characteristics of the autoantibodies; mechanisms of cell destruction. Ser Haemat 7:328–347.Google Scholar
  28. 28.
    Fehr J, Hofmann V, Kappeier U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. N Engl J Med 306:1254–1258.PubMedCrossRefGoogle Scholar
  29. 29.
    Fliedner V von, Higby DJ, Kim U (1982) Graft-versus-host reaction following blood product transfusion. Am J Med 72:951–961.CrossRefGoogle Scholar
  30. 30.
    Ford JM, Lucey JJ, Cullen MH, Tobins JS, Lister TA (1976) Fatal graft-versus-host disease following transfusion of granulocytes from normal donors. Lancet ii: 1167–1169.CrossRefGoogle Scholar
  31. 31.
    Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295–304.PubMedCrossRefGoogle Scholar
  32. 32.
    Glud TK, Rosthoj S, Jensen MK, Laursen B, Grunnet N, Jersild C (1983) High-dose intravenous immunoglobulin for post-transfusion purpura. Scand J Haematol 31:495–500.PubMedCrossRefGoogle Scholar
  33. 33.
    Goldman JM (1980) Haemopoietic stem cell autografts for leukaemia. Blut 41:71–79.PubMedCrossRefGoogle Scholar
  34. 34.
    Greenwalt TJ, Gajewski M, McKenna JL (1962) A new method for preparing buffy coat-poor blood. Transfusion 2:221–229.PubMedCrossRefGoogle Scholar
  35. 35.
    Grode G, Miripol J, Garber J, Barber T, Buch-holz DH (1985) Extended storage of platelets in a new plastic container. I. Biochemical and morphologic changes. Transfusion 25:204–208.PubMedCrossRefGoogle Scholar
  36. 36.
    Gross B, Hässig A, Luescher EF, Nydegger VE (1983) Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgG. Br J Haematol 53:289–299.PubMedCrossRefGoogle Scholar
  37. 37.
    Hamblin TJ, Navrose Abidi SM, Nee PA, Cop-plestone A, Mufti GJ, Oscier DG (1985) Successful treatment of post-transfusion purpura with high dose immunoglobulins after lack of response to plasma exchange. Vox Sang 49:164–167.PubMedCrossRefGoogle Scholar
  38. 38.
    Heinrich D, Mueller-Eckhardt C, Stier W (1973) The specificity of leukocyte and platelet alloantibodies in sera of patients with nonhemolytic transfusion reactions. Absorption and elution studies. Vox Sang 25:442–456.CrossRefGoogle Scholar
  39. 39.
    Higby DJ, Burnett D (1980) Granulocyte transfusions: current status. Blood 55:2–8.PubMedGoogle Scholar
  40. 40.
    Hillman LS, Goodwin SL, Sherman WR (1975) Identification and measurement of plasticiser in neonatal tissues after umbilical catheters and blood products. N Engl J Med 292:381–389.PubMedCrossRefGoogle Scholar
  41. 41.
    Hillman NM (1979) Fatal delayed hemolytic transfusion reaction due to anti-c + E. Transfusion 19:548–551.CrossRefGoogle Scholar
  42. 42.
    Hoffbrand AV, Gorman A, Laulicht M, Garidi M, Economidou J, Georgipoulou G, Hussain MAM, Flynn DM (1979) Improvement in iron status and liver function with long-term subcutaneous desferrioxamine. Lancet i : 947–949.CrossRefGoogle Scholar
  43. 43.
    Holland PV (1981) Other adverse effects of transfusion. In: Petz LD, Swisher SC (eds) Clinical Practice of Blood Transfusion. Churchill Livingstone, New York, p 783.Google Scholar
  44. 44.
    Holland PV, Wallerstein RO (1968) Delayed hemolytic transfusion reaction with acute renal failure. JAMA 204:1007–1008.PubMedCrossRefGoogle Scholar
  45. 45.
    Homburger HA, Smith JR, Jacob GL, Laschin-ger C, Naylor DH, Pineda AA (1981) Measurement of anti-IgA antibodies by a two-site im-munoradiometric assay. Transfusion 21:38–44.PubMedCrossRefGoogle Scholar
  46. 46.
    Honig CL, Bove JR (1980) Transfusion-associated fatalities: review of bureau of biologics reports 1976–1978. Transfusion 20:653–661.PubMedCrossRefGoogle Scholar
  47. 47.
    Hughes-Jones NC, Gardner B, Lincoln PJ (1971) Observations of the number of available c, D, and E antigen sites on red cells. Vox Sang 21:210–216.PubMedCrossRefGoogle Scholar
  48. 48.
    Imbach P, Barandun S, D’Apuzzo V, Baumgart-ner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet i: 1228–1230.CrossRefGoogle Scholar
  49. 49.
    International Forum (1978). What is the toxico-logical importance of the liberation of phthalates from plastic containers into blood, its components and derivatives? Vox Sang 34:244–254CrossRefGoogle Scholar
  50. 50.
    Jacob HAS, Craddock PR, Hammerschmidt DE, Moldow CF (1980) Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 302:789–794.PubMedCrossRefGoogle Scholar
  51. 51.
    Jaeger RJ, Rubin RJ (1972) Migration of a phtha-late ester plasticiser from polyvinyl chloride blood bags into stored human blood and its localization in human tissues. N Engl J Med 287:1114–1118.PubMedCrossRefGoogle Scholar
  52. 52.
    Judd WJ, Butch SH, Oberman HA, Steiner EA, Bauer RC (1980) The evaluation of a positive direct antiglobulin test in pretransfusion testing. Transfusion 20:17–23.PubMedCrossRefGoogle Scholar
  53. 53.
    Karp DD, Ervin DJ, Tuttle S, Gorgone BC, Lavin P, Yunis EJ (1982) Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang 42:57–61.PubMedCrossRefGoogle Scholar
  54. 54.
    Keimowitz RM, Collins J, Davis K, Aster RH (1986) Post-transfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka. Am J Hematol 21:79–88.PubMedCrossRefGoogle Scholar
  55. 55.
    Kernoff PBA, Durrant IJ, Rizza CR, Wrigth FW (1972) Severe allergic pulmonary edema after plasma transfusion. Br J Haematol 23:777–781.PubMedCrossRefGoogle Scholar
  56. 56.
    Kevy SV, Schmidt PJ, McGinniss MA, Workman WG (1962) Febrile, nonhemolytic transfusion reactions and the limited role of leukoagglutinins in their etiology. Transfusion 2:7–16.PubMedCrossRefGoogle Scholar
  57. 57.
    Kickler TS (1986) Blood 68, Suppl. 1:111a.Google Scholar
  58. 58.
    Kirmani S, Geier LJ, Gandara DR (1983) Posttransfusion purpura and isoimmune neonatal thrombocytopenia in the same family. A case report. (Abstract). Blood 62, Suppl. 1:245a.Google Scholar
  59. 59.
    Koistinen J, Leikola J (1977) Weak anti-IgA antibodies with limited specificity and nonhemolytic transfusion reactions. Vox Sang 32:77–81.PubMedCrossRefGoogle Scholar
  60. 60.
    Marcel YL, Noel SP (1970) Contamination of blood stored in plastic packs. Lancet i : 35–36.CrossRefGoogle Scholar
  61. 61.
    Marriott HL, Kekwick A (1940) Volume and rate in blood transfusion for relief of anemia. Br Med J i: 1043–1046.CrossRefGoogle Scholar
  62. 62.
    Marshall BE, Wurzel BA, Ellison N, Neufeld GR, Soma LR (1975) Microaggregate formation in stored blood. III. Comparison of Bentley, Fen-wal, Pall and Swank micropore filtration. Circ Shock 2:249–263.Google Scholar
  63. 63.
    McGinnis MH, Goldfinger D (1971) Comm Amer Assoc Blood Banks, Chicago.Google Scholar
  64. 64.
    Menitove JE, McElligott MC, Aster RH (1982) Febrile transfusion reaction: what blood component should be given next? Vox Sang 42:318–321.PubMedCrossRefGoogle Scholar
  65. 65.
    Michel J, Sharon R (1980) Non-haemolytic adverse reaction after transfusion of a blood unit containing penicillin. Brit Med J 280:152–153.PubMedCrossRefGoogle Scholar
  66. 66.
    Modell CB (1975) Transfusion and haemochro-matosis. In: Iron Metabolism and Its Disorders. Kiel H (ed) Excerpta Medica, Amsterdam.Google Scholar
  67. 67.
    Mollison PL (1959a) Blood group antibodies and red cell destruction. Brit Med J ii: 1035–1041.CrossRefGoogle Scholar
  68. 68.
    Mollison PL (1959b) Blood group antibodies and red cell destruction. Brit Med J ii:1123–1130.CrossRefGoogle Scholar
  69. 69.
    Mollison PL (1979) Blood Transfusion in Clinical Medicine. 5th Ed, Blackwell Sci Publ, Oxford, pp 567–568.Google Scholar
  70. 70.
    Mollison PL (1983) Blood Transfusion in Clinical Medicine. 7th Ed, Blackwell Sci Publ, Oxford.Google Scholar
  71. 71.
    Mueller-Eckhardt C (1986) Annotation, Posttransfusion purpura. Br J Haematol 64:419–424.PubMedCrossRefGoogle Scholar
  72. 72.
    Mueller-Eckhardt C, Lechner K, Heinrich D, Marks H-J, Mueller-Eckhardt G, Bettelheim P, Breithaupt H (1980) Post-transfusion thrombocytopenic purpura: immunological and clinical studies in two cases and review of the literature. Blut 40:249–257.PubMedCrossRefGoogle Scholar
  73. 73.
    Mueller-Eckhardt C, Küenzlen E, Thilo-Körner D, Pralle H (1983) High-dose intravenous immunoglobulin for post-transfusion purpura. N Engl J Med 308:287.PubMedGoogle Scholar
  74. 74.
    Mueller-Eckhardt C, Kiefel V, Mueller-Eckhardt G, Bambauer R, Baur J, Behringhoff B, Deuss U, Heinrich D, Klein HO, Lechner K, Maas D, Panzer S, Sprenger R, Stählin H, Vahrson H (1986) Posttransfusion purpura. A survey of 13 cases. Klin Wschr. 64:1198–1203.PubMedCrossRefGoogle Scholar
  75. 75.
    Murphy S, Gardner FH (1975) Platelet storage at 22°C: role of gas transport across plastic containers in maintenance of viability. Blood 46:209–218.PubMedGoogle Scholar
  76. 76.
    Myhre BA (1980) Fatalities from blood transfusion. JAMA 244:1333–1335.PubMedCrossRefGoogle Scholar
  77. 77.
    Ouwehand WH, Bruin HG de, Timmengen EJ, Huiskes E, Lange GG de, Engelfriet CP (1984) Determination of the subclass profile of erythrocyte antibodies with continuous-flow cyto-fluorometry and the correlation with their activity in monocyte-driven antibody-dependent cytotoxicity. 18th Congress of the International Society of Blood Transfusion, Book of Abstracts p 32, Abstr S4–02.Google Scholar
  78. 78.
    Parker CW (1984) Mediators: release and function. In: Paul WE (ed) Fundamental Immunology. Raven Press, New York, p 697.Google Scholar
  79. 79.
    Parkman R, Mosier D, Umansky I, Cochran W, Carpenter CB, Rosen FS (1974) Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med 290:359–363.PubMedCrossRefGoogle Scholar
  80. 80.
    Patten E, Reddi CR, Riglin H, Edwards J (1982) Delayed hemolytic transfusion reaction caused by a primary immune response. Transfusion 22:248–250.PubMedCrossRefGoogle Scholar
  81. 81.
    Pegels JG, Bruynes ECE, Engelfriet CP, Borne AEG Kr von dem (1981) Post-transfusion purpura: a serological and immunochemical study. Br J Haematol 49:521–530.PubMedCrossRefGoogle Scholar
  82. 82.
    Perkins HA, Payne R, Ferguson J, Wood M (1966) Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang 11:578–600.PubMedCrossRefGoogle Scholar
  83. 83.
    Petz LD, Garratty G (1980) Acquired Immune Hemolytic Anemias. Churchill Livingstone, New York.Google Scholar
  84. 84.
    Phadke KP, Isbister JP (1980) Post transfusion purpura. Med J Aust i : 430–432.Google Scholar
  85. 85.
    Pineda AA, Brzica SM Jr, Taswell HF (1978) Hemolytic transfusion reaction. Recent experience in a large blood bank. Mayo Clinic Proc 53:378–388.Google Scholar
  86. 86.
    Propper RD, Cooper B, Rufo RR, Nienhuis AW, Anderson WF, Bunn HF, Rosenthal A, Nathan DG (1977) Continuous subcutaneous administration of deferoxamine in patients with iron overload. N Engl J Med 297:418–423.PubMedCrossRefGoogle Scholar
  87. 87.
    Propper RD, Button LN, Nathan DG (1980) New approaches to the transfusion management of thalassemia. Blood 55:55–60.PubMedGoogle Scholar
  88. 88.
    Quick AJ (1960) Influence of erythrocytes on the coagulation of blood. Am J Med Sci 239:101–110.CrossRefGoogle Scholar
  89. 89.
    Rabiner SF, O’Brien K, Peskin GW, Friedman LH (1970) Further studies with stroma-free hemoglobin solution. Ann Surg 171:615–622.PubMedCrossRefGoogle Scholar
  90. 90.
    Rappeport J, Mihm M, Reinherz E, Lopansri S, Parkman R (1979) Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet ii:717–720.CrossRefGoogle Scholar
  91. 91.
    Reinherz EL, Parkman R, Rappeport J, Rosen FS, Schlossman SF (1979) Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med 300:1061–1068.PubMedCrossRefGoogle Scholar
  92. 92.
    Reul GJ, Greenberg SD, Lefrak EA, McCollum WB, Beali AC Jr, Jordan GL (1973) Prevention of post-traumatic pulmonary insufficiency. Fine screen filtration of blood. Arch Surg 106:386–394.PubMedCrossRefGoogle Scholar
  93. 93.
    Reznikoff-Etievant MF, Dangu C, Lobet R (1981) HLA-B 8 antigen and anti-PlA1 alloimmunization. Tissue Antigens 18:66–68.PubMedCrossRefGoogle Scholar
  94. 94.
    Reznikoff-Etievant MF, Muller J-Y, Julien F, Pa-tereau C (1983) An immune response gene linked to MHC in man. Tissue Antigens 22:312–314.PubMedCrossRefGoogle Scholar
  95. 95.
    Richtlinien zur Blutgruppenbestimmung und Bluttransfusion, hrsg. von der Bundesärztekammer, 1. Auflage 1980 (eine weitere Auflage der Richtlinien steht vor dem Abschluß).Google Scholar
  96. 96.
    Ridgwell K, Tanner MJA, Anstee DJ (1984) The Rhesus (D) polypeptide is linked to the human erythrocyte cytoskeleton. FEBS Letters 174:7–10.PubMedCrossRefGoogle Scholar
  97. 97.
    Rie MA de, Plasvan Dalen CM van der, Engelfriet CP, Borne AEG Kr von dem (1985) The serology of febrile transfusion reactions. Vox Sang 49:126–134.PubMedCrossRefGoogle Scholar
  98. 98.
    Roelcke, D (1973) Specificity of IgA cold agglutinins: anti-Prx. Eur J Immunol 3:206–212.PubMedCrossRefGoogle Scholar
  99. 99.
    Root RK, Wolff SM (1968) Pathogenetic mechanisms in experimental immune fever. J Exp Med 128:309–323.PubMedCrossRefGoogle Scholar
  100. 100.
    Ropars C, Caldera LH, Griscelli C, Homberg JC, Salmon C (1974) Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to γ-globulin administration. Vox Sang 27:294–301.PubMedCrossRefGoogle Scholar
  101. 101.
    Ropars C, Cartron JP, Cartron J, Bäy P, Salmon C (1979) Human IgE response to the administration of blood components. I. Whole blood or washed red blood cells. Vox Sang 37:139–148.PubMedCrossRefGoogle Scholar
  102. 102.
    Rosen RD, Huestis DW, Corrigan JJ (1978) Acute leukemia and granulocyte transfusion: fatal graft-versus-host reaction following transfusion of cells obtained from normal donors. J Pe-diat 93:268–270.CrossRefGoogle Scholar
  103. 103.
    Rosenfield RE (1985) Letter to the Editor, Transfusion 25:182.PubMedCrossRefGoogle Scholar
  104. 104.
    Salama A, Mueller-Eckhardt C (1984) Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 24:188–193.PubMedCrossRefGoogle Scholar
  105. 105.
    Salama A, Mueller-Eckhardt C (1985) Letter to the Editor, Transfusion 25:182.CrossRefGoogle Scholar
  106. 106.
    Salama A, Mueller-Eckhardt C, Kiefel V (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet ii:193–195.CrossRefGoogle Scholar
  107. 107.
    Sandler G (1982) Amer Red Cross Blood Services. Letter 82–55, July 1.Google Scholar
  108. 108.
    Schechter JP, Soehnlen F, McFarland W (1972) Lymphocyte response to blood transfusion in man. N Engl J Med 287:1169–1173.PubMedCrossRefGoogle Scholar
  109. 109.
    Schmidmeier W, Feil W, Gebhart W, Grisold W, Gschnait F, Hinterberger W, Höcker P, Jellinger K, Krepler R, Machacek E (1982) Fatal graft-versus-host reaction following granulocyte transfusions. Blut 45:115–119.PubMedCrossRefGoogle Scholar
  110. 110.
    Schmidt PJ (1980) Clinical-pathological concepts of hemolytic transfusion reactions. In: Immuno-biology of the Erythrocyte. Sandler SG and Ja-mieson GA (eds) Alan R Liss Inc, New York.Google Scholar
  111. 111.
    Schmidt PJ, Holland PV (1967) Pathogenesis of the acute renal failure associated with incompatible transfusion. Lancet ii: 1169–1172.CrossRefGoogle Scholar
  112. 112.
    Schmidt PJ, Kevy SV (1963) Sources of error in a hospital blood bank. Transfusion 3:198–201.PubMedCrossRefGoogle Scholar
  113. 113.
    Schmidt PJ, Nancarrow JF, Morrison EG, Chase C (1959) A hemolytic reaction due to the transfusion of Ax blood. J Lab Clin Med 54:38–41.PubMedGoogle Scholar
  114. 114.
    Shulman NR (1964) A mechanism of cell destruction in individuals sensitized of foreign antigens and its implications in auto-immunity. Ann Intern Med 60:506–521.PubMedCrossRefGoogle Scholar
  115. 115.
    Shulman NR, Jordan JV (1982) Platelet immunology. Hemostasis and Thrombosis (ed. by R. W. Colman, J. Hirsh, V. J. Marder and E. W. Salzman), p. 274. J. B. Lippincott, Philadelphia.Google Scholar
  116. 116.
    Shulman NR, Aster RH, Leitner A, Hiller MC (1961) Immune reactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in »autoimmunity«. J Clin Invest 40:1597–1620.PubMedCrossRefGoogle Scholar
  117. 117.
    Sonnenberg CL, Taswell HF (1984) Error analysis: methods of detection, analysis and control. In: Smit Sibinga C TH, Das PC, Taswell HF (eds) Quality Assurance in Blood Banking and Its Clinical Impact. Martinus Nijkoff Publ, Boston, pp 238–246.Google Scholar
  118. 118.
    Soulier J-P, Patereau C, Gobert N, Achach P, Muller J-Y (1979) Posttransfusional immunologic thrombocytopenia. A case report. Vox Sang 37:21–29.PubMedCrossRefGoogle Scholar
  119. 119.
    Sultan Y, Kazatchkine ME, Maisonneuve P, Ny-degger VE (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet ii:765–771.CrossRefGoogle Scholar
  120. 120.
    Taaning E, Morling N, Ovesen H, Svejgaard A (1985) Post transfusion purpura and anti-Zwb (-P1A2). Tissue Antigens 26:143–146.PubMedCrossRefGoogle Scholar
  121. 121.
    Taswell HF, Sonnenberg CL (1984) Error analysis: types of errors in the blood bank. In: Smit Sibinga C TH, Das PC, Taswell HF (eds) Quality Assurance in Blood Banking and Its Clinical Impact. Martinus Nijkoff Publ, Boston, pp 227–237.CrossRefGoogle Scholar
  122. 122.
    Taswell HF, Smith AM, Sweatt MA, Pfaff KJ (1974) Quality control in the blood bank. A new approach. Am J Clin Pathol 62:491–495.PubMedGoogle Scholar
  123. 123.
    Taswell HF, Pineda AA, Moore SB (1981) Hemolytic transfusion reactions: frequency and clinical and laboratory aspects. In: Bell CA (ed) A Seminar on Immune-Mediated Cell Destruction. Am Assoc Blood Banks pp 71–92.Google Scholar
  124. 124.
    Technical Manual of the American Association of Blood Banks (1985a) 9th edn, p 276.Google Scholar
  125. 125.
    Technical Manual of the American Association of Blood Banks (1985b) 9th Ed, p 335.Google Scholar
  126. 126.
    Thulstrup H (1971) The influence of leukocyte and thrombocyte incompatibility on non-hae-molytic transfusion reactions. I. A retrospective study. Vox Sang 21:233–250.PubMedCrossRefGoogle Scholar
  127. 127.
    Tsubakio T, Kurata Y, Katagiri S, Kanakura Y, Tamaki T, Kuyama J, Kanayama Y, Yonezawa T, Tarui S (1983) Alteration of T cell subset and immunoglobulin synthesis in vitro during high dose γ-globulin therapy in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol 53:697–702.PubMedGoogle Scholar
  128. 128.
    Verheugt FWA, Borne AEG Kr von dem, Décary F, Engelfriet CP (1977) The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haemat 36:533–544.CrossRefGoogle Scholar
  129. 129.
    Vyas GN, Holmdahl L, Perkins HA, Fudenberg HH (1969) Serologic specificity of human anti-IgA and its significance in transfusion. Blood 34:573–581.PubMedGoogle Scholar
  130. 130.
    Waal LP de, Dalen CM van, Engelfriet CP, Borne AEG Kr von dem (1986) Alloimmunization against the platelet-specific Zwaantigen, resulting in neonatal alloimmune thrombocytopenia or posttransfusion purpura, is associated with the supertypic DRw 52 antigen including DR 3 and DRw 6. Human Immunology 17:45–53.PubMedCrossRefGoogle Scholar
  131. 131.
    Weatherall DJ (1974) Protein synthesis in the red cell: the thalassaemias and related disorders. In: Blood and Its Disorders. Hardisty RM, Weatherall DJ (eds) Blackwell Sci Publ, Oxford.Google Scholar
  132. 132.
    Weiden PL, Zuckerman N, Hansen JA, Sale GE, Remlinger K, Beck TM, Buckner CD (1981) Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusions. Blood 57:328–332.PubMedGoogle Scholar
  133. 133.
    Wells JV, King MA (1980) Adverse reactions to plasma proteins. Anaesth Inten Care 8:139–144.Google Scholar
  134. 134.
    Westphal O (1956) Pyrogens. In: Polysaccharides in Biology. Transactions 2nd Conf Josiah Macy Jr Foundation, New York, p 115.Google Scholar
  135. 135.
    Wiener AS, Samwick AA, Morrison H, Cohen L (1953) Studies on immunization in man. I. The blood group substances A and B. Exp Med Surg 11:267–275.Google Scholar
  136. 136.
    Woods WG, Lubin BH (1981) Fatal graft-versus-host disease following a blood transfusion in a child with neuroblastoma. Pediat 67:217–221.Google Scholar
  137. 137.
    Yap PL, Pryde EAD, McClelland DBL (1982) IgA content of frozen-thawed-washesd red blood cells and blood products measured by radioimmunoassay. Transfusion 22:36–38.PubMedCrossRefGoogle Scholar
  138. 138.
    Zettner A, Bove JR (1963) Hemolytic transfusion reaction due to interdonor incompatibility. Transfusion 3:48–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • D. Roelcke

There are no affiliations available

Personalised recommendations